Toxicological Research

Korean Society of Toxicology & Korea Environmental Mutagen Society (한국독성학회)
권호 표지

The Recommended Approaches and Recent Trends in Reproductive and Developmental Toxicology

생식 · 발생독성시험의 방법적 고찰과 최신 연구 동향

  • Published : 2005.12.01
Download PDF
⟨ Previous Next ⟩

Abstract

Reproductive and developmental toxicology is concerned with various physical or chemical agents interfering with fertility in both gender or normal growth of offsprings. Reproductive and developmental toxicology is rather a complex science, with many fields, i.e., various endpoints are involved and many different mechanisms of action. For that reason, diverse aspects must be considered when attempting to assess possible adverse health effects in the area of reproductive and developmental toxicology. The thalidomide tragedy made it clear to regulatory authorities around the world that systematic, comprehensive evaluation of the reproductive cycle was needed to adequately evaluate the potential of medicinal drugs to impair the process of reproduction or the development of embryos, fetuses, and children. International Conference on Harmonization of Technical Requirements for the Registration of Pharmaceuticals for Human Use (ICH) and U.S. Food and Drug Administration (FDA) developed a guideline to assess the reproductive and developmental toxicity. Also these guidelines have since been applied to the detection and regulation of environmental toxicants, food additives, and so on. Although it was hoped that testing procedures of guideline would be updated constantly to reflect the current state of the science in reproductive and developmental toxicology, it was not until this decade that regulatory guidelines and testing methods have been altered in a significant way. In this paper, we would like to present the recommended approaches and recent trends for improvement of testing guidelines or experimental methods in reproductive and developmental toxicology.

Keywords

References

  1. Andersen, M.E., Thomas, R.S., Gaido, K.W. and Conolly, R.B. (2005): Dose-response modeling in reproductive toxicology in the systems biology era. Reprod. Toxicol., 19, 327-337 https://doi.org/10.1016/j.reprotox.2004.12.004
  2. Boekelheide, K. and Chapin, R.E. (1997): Male reproductive toxicology. In: Sipes, I.G., McQueen, C.A., Gandolfi, A.J., eds. Comprehensive toxicology, vol. 10. Elsevier Science, New York, p.1-3
  3. Brewis, I.A. (1999): Proteomics in reproductive research: the potential importance of proteomics to research in reproduction. Hum. Reprod., 14, 2927-2929 https://doi.org/10.1093/humrep/14.12.2927
  4. Chapin, R.E. and Sloane, R.A. (1997): Reproductive assess-ment by continuous breeding: evolving study design and summaries of ninty studies. Environ. Health Perspect., 105, 199-205 https://doi.org/10.2307/3433407
  5. Coliins, T.F., Sprando, R.L., Shackelford, M.E, Hansen, D.K. and Welsh, J.J. (1999a): Food and Drug Administration proposed testing guidelines for reproduction studies. Regul. Toxicol. Pharmacol., 30, 29-38 https://doi.org/10.1006/rtph.1999.1306
  6. Coli ins, T.F., Sprando, R.L., Shackelford, M.E, Hansen, D.K. and Welsh, J.J. (1999b): Food and Drug Administration proposed testing guidelines for developmental toxicity studies. Regul. Toxicol. Pharmacol., 30, 39-44 https://doi.org/10.1006/rtph.1999.1307
  7. Daston, G.P. and Naciff, J.M. (2005): Gene expression changes related to growth and differentiation in the fetal and juvenile reproductive system of the female rat: evaluation of microarray results. Reprod. Toxicol., 19, 381-394 https://doi.org/10.1016/j.reprotox.2004.09.004
  8. Endo, M., Matsubara, H., Kokubun, T., Masuko, H., Takahata, Y., Tsuchiya, T., Fukuda, H., Demuta, T. and Watanabe, M. (2002): The advantages of cDNA microarray as an effective tool for identification of reproductive organ-specific genes in a model legume, Lotus japonicus. FEBS Lett., 514, 229-237 https://doi.org/10.1016/S0014-5793(02)02371-2
  9. Environmental Protection Agency (EPA) (1991): Pesticide assessment guidelines, subdivision F. Hazard evaluation: human and domestic animals. Addendum 10: Neurotoxicity, series 81, 82, and 83. Office of Prevention, Pesticides and Toxic substances, Washington, DC. EPA 540/09-91123
  10. Environmental Protection Agency (EPA) (1998): Guidelines for neurotoxicity risk assessment; notice. Fed. Regist., 63, 26926-26954
  11. Food and Drug Administration (FDA) (1998): Regulations requiring manufacturers to assess the safety and effectiveness of new drugs and biological products in pediatric patients. Fed. Regist., 63, 66632-66672
  12. Food and Drug Administration (FDA) (2000): Toxicological principles for the safety of food ingredients, Redbook 2000, US Food and Drug Administration, Center for Food Safety and Applied Nutrition
  13. Froment, P., Staub, C., Hembert, S., Pisselet, C., Magistrini, M., Delaleu, B., Seurin, D., Levine, J.E., Johnson, L., Binoux, M. and Monget, P. (2004): Reproductive abnormalities in human insulin-like growth factor-binding protein-1 transgenic male mice. Endocrinology, 145, 2080-2091 https://doi.org/10.1210/en.2003-0956
  14. Grasso, P., Heindel, J.J., Powel, C.J. and Reichert, L.E. Jr. (1993): Effects of mono(2-ethylhexyl) phthalate, a testicu-lar toxicant, on follicle-stimulating hormone binding to membranes from cultured rat Sertoli cells. Biol. Reprod., 48, 454-459 https://doi.org/10.1095/biolreprod48.3.454
  15. Kawaguchi, M., Funabashi, T., Aiba, S. and Kimura, F. (2002): Butyl benzyl phthalate, an endocrine disrupter, inhibits pulsatile luteinizing hormone secretion under an insulin-induced hypoglycaemic state in ovariectomized rats. J. Neuroendocrinol., 14, 486-491 https://doi.org/10.1046/j.1365-2826.2002.00804.x
  16. Lanning, L.L., Creasy, D.M., Chapin, R.E., Mann, P.C., Barlow, N.J., Regan, K.S. and Goodman, D.G. (2002): Recommended approaches for the evealuation of testicular and epididymal toxicity. Toxicol. Pathol., 30, 507-520 https://doi.org/10.1080/016128401750063376
  17. Li, S.H., Lee, R.K., Chen, P.W, Lu, C.H., Wang, S.H. and Hwu, Y.M. (2005): Differential expression and distribution of alternatively spliced transcripts of PDGF-A and of PDGF receptor-alpha in mouse reproductive tissues. Life Sci., 77, 2412-2424 https://doi.org/10.1016/j.lfs.2005.01.030
  18. Meistrich, M.L., Wilson, G., Shuttlesworth, G.A. and Porter, K.L. (2003): Dibromochloropropane inhibits spermatogonial development in rats. Reprod. Toxicol., 17, 263-271 https://doi.org/10.1016/S0890-6238(03)00007-8
  19. Overstreet, J.W., Samules, S.J. and Day, P. (1988): Early indicators of male reproductive toxicity. Risk Analysis, 8, 21-26 https://doi.org/10.1111/j.1539-6924.1988.tb01150.x
  20. Rhee, G.S., Cho, D.H., Won, Y.H., Seok, J.H., Kim, S.S., Kwack, S.J., Lee, R.D., Chae, S.Y., Kim, J.W., Lee, B.M., Park, K.L. and Choi, K.S. (2005): Multigeneration reproductive and developmental toxicity study of bar gene inserted into genetically modified potato on rats. J. Toxicol. Environ. Health, 68, 2263-2276 https://doi.org/10.1080/15287390500182446
  21. Rulli, S.B., Ahtiainen, P., Makela, S., Toppari, J., Poutanen, M. and Huhtaniemi, I. (2003): Elevated steroidogenesis, defective reproductive organs, and infertility in transgenic male mice overexpressing human choionic gonadotropin. Endocrinology, 144, 4980-4990 https://doi.org/10.1210/en.2003-0403
  22. Schwartz, S. (2001): Providing toxicokinetic support for reproductive toxicology studies in pharmaceutical development. Arch. Toxicol., 75, 381-387 https://doi.org/10.1007/s002040100255
  23. Son, W.C., Kim, J.C. and Yu, I.J. (2003): The recommended approaches for the evaluation of testicular toxicity with awareness of the spermatogenic cycle and quantitative testicular toxicity evaluation methods. J. Toxicol. Pub. Health, 19, 83-90
  24. The ICH Guidelines for Detection of Toxicity to Reproduction for Medical Products (S5A) Including Addendum S5B and S5M(M): Toxicity on Male Fertility (issued October 1996 and November 2000, Respectively)